Connection

PRADIP SAHA to Diabetes Mellitus, Type 2

This is a "connection" page, showing publications PRADIP SAHA has written about Diabetes Mellitus, Type 2.
Connection Strength

0.240
  1. The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice. Cell Metab. 2022 12 06; 34(12):1932-1946.e7.
    View in: PubMed
    Score: 0.102
  2. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell. 2011 Dec; 10(6):996-1010.
    View in: PubMed
    Score: 0.048
  3. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006 May; 3(5):379-86.
    View in: PubMed
    Score: 0.033
  4. Loss of bone morphogenetic protein-binding endothelial regulator causes insulin resistance. Nat Commun. 2021 03 26; 12(1):1927.
    View in: PubMed
    Score: 0.023
  5. miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity. Diabetes. 2018 12; 67(12):2541-2553.
    View in: PubMed
    Score: 0.019
  6. Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice. FASEB J. 2015 Aug; 29(8):3537-48.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.